Russell Investments Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13K | Buy |
+142
| New | +$2.13K | ﹤0.01% | 3583 |
|
|
2024
Q4 | – | Sell |
-129
| Closed | -$3.79K | – | 3791 |
|
|
2024
Q3 | $3.79K | Buy |
+129
| New | +$3.79K | ﹤0.01% | 3273 |
|
|
2022
Q2 | – | Sell |
-120
| Closed | -$6K | – | 2962 |
|
|
2022
Q1 | $6K | Hold |
120
| – | – | ﹤0.01% | 2726 |
|
|
2021
Q4 | $14K | Hold |
120
| – | – | ﹤0.01% | 2966 |
|
|
2021
Q3 | $23K | Sell |
120
-841
| -88% | -$161K | ﹤0.01% | 2992 |
|
|
2021
Q2 | $165K | Sell |
961
-2,418
| -72% | -$415K | ﹤0.01% | 2957 |
|
|
2021
Q1 | $668K | Sell |
3,379
-2,261
| -40% | -$447K | ﹤0.01% | 2400 |
|
|
2020
Q4 | $1.11M | Sell |
5,640
-981
| -15% | -$193K | ﹤0.01% | 2076 |
|
|
2020
Q3 | $1.17M | Buy |
6,621
+4,007
| +153% | +$709K | ﹤0.01% | 1992 |
|
|
2020
Q2 | $603K | Buy |
2,614
+114
| +5% | +$26.3K | ﹤0.01% | 2305 |
|
|
2020
Q1 | $290K | Sell |
2,500
-3,594
| -59% | -$417K | ﹤0.01% | 2412 |
|
|
2019
Q4 | $1.16M | Hold |
6,094
| – | – | ﹤0.01% | 2032 |
|
|
2019
Q3 | $1.17M | Buy |
6,094
+6,078
| +37,988% | +$1.17M | ﹤0.01% | 1937 |
|
|
2019
Q2 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 2838 |
|